Abstract
BACKGROUND: Nebulised pentamidine is effective for preventing Pneumocystis carinii pneumonia in adults with acquired immunodeficiency syndrome. The nebuliser dose required to produce equivalent lung concentrations of pentamidine in children is unknown. This study was performed to measure pulmonary pentamidine deposition in children and to relate this to age, ventilation pattern, and body size. METHODS: Nebulised pentamidine (50 mg in 6 ml saline) was administered to 12 children (including one with lymphocytic interstitial pneumonitis) and to six adults with human immunodeficiency virus infection using a Respirgard II nebuliser. Technetium-99m labeled colloidal human serum albumin was used as an indirect marker for pentamidine and deposition in the lungs was detected by a gamma camera. RESULTS: Absolute deposition of pentamidine was not related to age, height, weight, spirometry, or ventilation characteristics. Deposition, as a mean (SD) percentage of nebuliser output, was similar in children aged 8-11 years (5.5(2.4)%), teenagers aged 12-15 years (7.2(2.2)%) and adults (7.1(2.6)%). Aerosol concentration within the lungs (% nebuliser output deposited/predicted total lung capacity) was therefore higher in children (1.9(1.5)%/1) and teenagers (1.9(0.7)%/1) than in adults (1.0(0.7%)/1), and was negatively correlated with height (r = -0.69) and weight (r = -0.50). Deposition of aerosol in the region of the large central airways was particularly marked in children. Small reductions in forced expiratory volume in one second and forced vital capacity after treatment did not differ significantly between adults and children and visual analogue scores of subjective adverse effects did not vary with age. CONCLUSIONS: These results suggest that children probably require lower nebuliser pentamidine doses to produce lung pentamidine concentrations equivalent to those found to be effective for preventing P carinii pneumonia in adults using the Respirgard II nebuliser.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blackhall M. I., O'Donnell S. R. A dose-response study of inhaled terbutaline administered via Nebuhaler or nebuliser to asthmatic children. Eur J Respir Dis. 1987 Aug;71(2):96–101. [PubMed] [Google Scholar]
- Collis G. G., Cole C. H., Le Souëf P. N. Dilution of nebulised aerosols by air entrainment in children. Lancet. 1990 Aug 11;336(8711):341–343. doi: 10.1016/0140-6736(90)91880-j. [DOI] [PubMed] [Google Scholar]
- Fleming J. S. A technique for the absolute measurement of activity using a gamma camera and computer. Phys Med Biol. 1979 Jan;24(1):176–180. doi: 10.1088/0031-9155/24/1/017. [DOI] [PubMed] [Google Scholar]
- Hirschel B., Lazzarin A., Chopard P., Opravil M., Furrer H. J., Rüttimann S., Vernazza P., Chave J. P., Ancarani F., Gabriel V. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med. 1991 Apr 18;324(16):1079–1083. doi: 10.1056/NEJM199104183241602. [DOI] [PubMed] [Google Scholar]
- Leoung G. S., Feigal D. W., Jr, Montgomery A. B., Corkery K., Wardlaw L., Adams M., Busch D., Gordon S., Jacobson M. A., Volberding P. A. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med. 1990 Sep 20;323(12):769–775. doi: 10.1056/NEJM199009203231201. [DOI] [PubMed] [Google Scholar]
- Lourenço R. V., Loddenkemper R., Carton R. W. Patterns of distribution and clearance of aerosols in patients with bronchiectasis. Am Rev Respir Dis. 1972 Dec;106(6):857–866. doi: 10.1164/arrd.1972.106.6.857. [DOI] [PubMed] [Google Scholar]
- Macey D. J., Marshall R. Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J Nucl Med. 1982 Aug;23(8):731–734. [PubMed] [Google Scholar]
- Montaner J. S., Lawson L. M., Gervais A., Hyland R. H., Chan C. K., Falutz J. M., Renzi P. M., MacFadden D., Rachlis A. R., Fong I. W. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study. Ann Intern Med. 1991 Jun 1;114(11):948–953. doi: 10.7326/0003-4819-114-11-948. [DOI] [PubMed] [Google Scholar]
- O'Doherty M. J., Thomas S., Page C., Clark A. R., Mitchell D., Heduan E., Nunan T. O., Bateman N. T. Does 99Tcm human serum albumin alter the characteristics of nebulized pentamidine isethionate? Nucl Med Commun. 1989 Jul;10(7):523–529. doi: 10.1097/00006231-198907000-00013. [DOI] [PubMed] [Google Scholar]
- Thomas S. H., O'Doherty M. J., Graham A., Page C. J., Blower P., Geddes D. M., Nunan T. O. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers. Thorax. 1991 Oct;46(10):717–721. doi: 10.1136/thx.46.10.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas S. H., O'Doherty M. J., Page C. J., Nunan T. O., Bateman N. T. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur Respir J. 1991 May;4(5):616–622. [PubMed] [Google Scholar]
- Thomas S. H., O'Doherty M. J., Page C. J., Nunan T. O. Variability in the measurement of nebulized aerosol deposition in man. Clin Sci (Lond) 1991 Dec;81(6):767–775. doi: 10.1042/cs0810767. [DOI] [PubMed] [Google Scholar]
- Wolfsdorf J., Swift D. L., Avery M. E. Mist therapy reconsidered; an evaluation of the respiratory deposition of labelled water aerosols produced by jet and ultrasonic nebulizers. Pediatrics. 1969 May;43(5):799–808. [PubMed] [Google Scholar]
- Wolfsdorf J., Swift D. L., Avery M. E. Mist therapy reconsidered; an evaluation of the respiratory deposition of labelled water aerosols produced by jet and ultrasonic nebulizers. Pediatrics. 1969 May;43(5):799–808. [PubMed] [Google Scholar]
